New study tracks blood sugar swings in cancer patients with diabetes
NCT ID NCT07180251
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how daily ups and downs in blood sugar affect people who have both gastrointestinal cancer and diabetes after surgery. Researchers will track 260 participants to see if these changes impact self-care, blood sugar control, emotional distress, fatigue, and quality of life. In the second phase, some participants will try an 8-week education program using a continuous glucose monitor to help them better manage their health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CARE program (education with continuous glucose monitoring)
- What this could lead to
- If successful, this could lead to a better way to help people manage both diabetes and recovery after GI cancer surgery, improving their daily life and emotional well-being.
- What could go wrong
- This is an early-stage study with no control group for the main analysis, so results may not apply broadly. The intervention is behavioral, so benefits may vary by individual.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLETUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital
Taipei, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New platform aims to personalize cancer treatment for GI patients
- Could some GI cancer patients avoid major surgery? new study explores organ preservation
- New pill may help diabetics fast safely during ramadan
- Could silkworm pupas be the key to fighting muscle loss in cancer survivors?
- New hope for stomach and bowel cancers: experimental drug Rina-S enters Mid-Stage trial
- New hope for stomach cancer: experimental drug BHB810 enters human trials